skip to Main Content

LED Medical Diagnostics Subsidiary Apteryx, Inc. Awarded a Five-Year Contract With the United States Dept. of Veteran’s Affairs Federal Supply Schedule (FSS)

  • September 20, 2018
  • News Releases

Vancouver, BC – September 20, 2018 – LED Medical Diagnostics Inc. (“LED Medical” or “the Company”) is pleased to announce that its wholly-owned subsidiary, Apteryx, Inc., has been awarded a VA Federal Supply Schedule (FSS) 65 II C contract for Dental Equipment and Supplies. The five year contract, # 36F79718D0582, is effective from 9/15/2018 through 9/14/2023 and includes a renewal option for an additional five year period. The contract award provides Apteryx the ability to serve as a preferred supplier of dental imaging products, software and services to United States government institutions worldwide.

“This award expands our reach to U.S. government agencies and helps us build upon our existing customer relationships within the Department of Defense,” stated Dr. David Gane, CEO of LED Medical.

Delegated authority by the General Services Administration (GSA), the VA Federal Supply Schedule (FSS) program supports the healthcare acquisition needs of the VA and other government agencies. By utilizing this FSS contract vehicle, government buyers enjoy the benefits of pre-negotiated pricing, guaranteeing the government best-value solutions, pre-negotiated terms and conditions, greatly reduced paperwork, significantly expedited delivery and ease of meeting small business goals.

“We are proud to be recognized as a preferred supplier to the United States government on the dental technology schedule,” Gane concluded. “We anticipate a mutually rewarding future in working with U.S. government agencies.”

Government agencies interested in learning more about dental imaging technologies from Apteryx may visit or call 844.952.7327.

About LED Medical Diagnostics Inc.

LED Medical Diagnostics Inc. is a dental imaging technology provider focused on delivering state-of-the-art imaging software and systems. Through its wholly-owned subsidiaries LED Dental Inc., LED Dental Ltd., and Apteryx, Inc., LED Medical has provided dentists and oral health specialists with advanced diagnostic imaging products and software for over 20 years. LED’s proprietary technologies include the VELscope Vx Enhanced Oral Assessment and TUXEDO Intraoral Sensors, in addition to Apteryx’s XrayVision, XVWeb and XrayVision DCV imaging software solutions.

Backed by an experienced leadership team and dedicated to a higher level of service and support, LED is committed to providing dental practitioners with the best technology available by identifying and adding leading products to its growing portfolio. The Company is currently listed on the TSX-V under the symbol LMD, the OTCQB under the symbol LEDIF, as well as the Frankfurt Stock Exchange under the symbol LME.

Media Contact:

LED Dental
Chris Koch
Phone: 678.293.9413

Corporate Contact:

LED Medical
David Gane, CEO
Phone: 604.434.4614 x227

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Forward Looking Statements

This press release contains statements which, to the extent that they are not recitations of historical fact, may constitute forward-looking information under applicable Canadian securities legislation that involve risks and uncertainties. Such forward-looking statements or information include statements regarding, but not limited to the Company’s future growth strategy, its distribution strategy and product offerings, potential expansion of the Company’s technology to other medical applications or markets, or the potential introduction of new technologies by the Company. Persons reading this press release are cautioned that such statements or information are only predictions, and that the Corporation’s actual future results or performance may be materially different. Factors that could cause actual events or results to differ materially from those suggested by these forward-looking statements include, but are not limited to competition risks, distributor risks, product development risks such as regulatory, design, intellectual property and other factors described in the Corporation’s reports filed on SEDAR including its Annual Information Form and financial report for the year ended December 31, 2017.  These and other factors should be considered carefully and readers should not place undue reliance on such forward-looking information. All forward-looking statements made in this press release are qualified by this cautionary statement and there can be no assurance that actual results or developments anticipated by the Company will be realized. The Company disclaims any intention or obligation to update or revise forward-looking information, whether as a result of new information, future events or otherwise, except as required by law.

Back To Top